Education
About Us
Working with TipRanks
Follow Us
Nkgen Biotech Inc. (NKGN)
:NKGN
NKGN Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.10 - $1.37
Previous CloseN/A
Volume116.73K
Average Volume (3M)150.24K
Market Cap
$13.48M
Enterprise Value$174.11M
Total Cash (Recent Filing)$8.00K
Total Debt (Recent Filing)$30.74M
Price to Earnings (P/E)―
Beta0.88
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.29
Shares Outstanding44,947,590
10 Day Avg. Volume200,006
30 Day Avg. Volume150,235
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)-3.22
Price to Sales (P/S)0.00
P/FCF Ratio-6.12
Enterprise Value/Market Cap12.91
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-278.13
Enterprise Value/Ebitda-0.64
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
NKGen Biotech News
PremiumCompany Announcements
NKGen Biotech Approved as Preferred Bidder for NKMAX
PremiumCompany Announcements
NKGen Biotech Enters Stock Purchase AgreementPremiumCompany Announcements
NKGen Biotech Delays Quarterly Report Filing
PremiumCompany Announcements
NKGen Biotech’s Strategic Stock Purchase AgreementOptions Prices
Currently, No data available
---
Ownership Overview
56.82% Insiders
0.78% Mutual Funds
1.99% Other Institutional Investors
40.41% Public Companies and
Individual Investors
NKGN FAQ
What was Nkgen Biotech Inc.’s price range in the past 12 months?
Nkgen Biotech Inc. lowest stock price was $0.10 and its highest was $1.37 in the past 12 months.
What is Nkgen Biotech Inc.’s market cap?
Nkgen Biotech Inc.’s market cap is $13.48M.
When is Nkgen Biotech Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Nkgen Biotech Inc.’s earnings last quarter?
Nkgen Biotech Inc. released its earnings results on Nov 14, 2023. The company reported -$2.476 earnings per share for the quarter, missing the consensus estimate of N/A by -$2.476.
Is Nkgen Biotech Inc. overvalued?
According to Wall Street analysts Nkgen Biotech Inc.’s price is currently Overvalued.
Does Nkgen Biotech Inc. pay dividends?
Nkgen Biotech Inc. does not currently pay dividends.
What is Nkgen Biotech Inc.’s EPS estimate?
Nkgen Biotech Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Nkgen Biotech Inc. have?
Nkgen Biotech Inc. has 44,947,590 shares outstanding.
What happened to Nkgen Biotech Inc.’s price movement after its last earnings report?
Nkgen Biotech Inc. reported an EPS of -$2.476 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 0.35%.
Which hedge fund is a major shareholder of Nkgen Biotech Inc.?
Currently, no hedge funds are holding shares in NKGN
NKGen Biotech Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Hedge Fund Trend
Decreased
By 549.4K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $4.9M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Neutral
Last 7 Days ▼ 1.0%
Last 30 Days ▲ 1.7%
Last 30 Days ▲ 1.7%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-75.20%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-73.76%
Trailing 12-Months
Company Description
Nkgen Biotech Inc.
Graf Acquisition Corp. IV does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other business combination with one or more businesses. Graf Acquisition Corp. IV was incorporated in 2021 and is based in The Woodlands, Texas.
Technical Analysis
Palatin Technologies
―
GT Biopharma
―
Creative Medical Technology Holdings
―
Spruce Biosciences
―
Apollomics
―